Renee Wegrzyn, PhD, Director of the Advanced Research Projects Agency for Health (ARPA-H), announced funding of three new programs to support the Cancer Moonshot during a Cancer Moonshot Mission Update hosted by POLITICO. The programs are:
• Targeted Hybrid Oncotherapeutic Regulation (THOR): $45 million to Rice University to develop a minimally invasive implant that senses and responds with a specific treatment and will trigger the immune system against tumors.
• Synthetic Programmable bacteria for Immune-directed Killing in tumor Environments (SPIKEs): Up to $19 million to the University of Missouri to develop an inexpensive and safe therapy using bacteria specifically selected for tumor-targeting.
• Cancer and Organ Degradome Atlas (CODA): Up to $50 million to the Georgia Institute of Technology to map cancer cell biomarkers to drastically improve multi-cancer early detection and streamline clinical intervention when tumors are still small.
Danielle Carnival, PhD, Deputy Assistant to the President for the Cancer Moonshot, reiterated the collaboration and non-duplicative efforts among ARPA-H and the National Cancer Institute during the update. She also emphasized the relationship between innovative technology and access to care, emphasizing preventive care and early detection.
For more information, contact Katie Grady, American College of Radiology® Director of Government Affairs.
Make America Healthy Again
President Trump released an Executive Order (EO) establishing the "Make America Healthy Again (MAHA) Commission,” Feb. 13 to be led by the new Department of Health and Human Services Secretary Robert F. Kennedy Jr.
Read moreScope of Practice Bills Introduced At State Legislative Level
The American College of Radiology® (ACR®) is tracking more than 58 scope of practice bills across 22 states with more expected to be considered.
Read moreACR Others Challenge MAC Position on Minimally Invasive Arthrodesis of the Sacroiliac Joint
The American College of Radiology® (ACR®) and other medical specialty societies that use or perform interventional pain and spine procedures told three of the seven Medicare Administrative Contractors (MACs) that implementation of a new policy as written could limit access to a safe, effective and durable treatment option, potentially exacerbating healthcare disparities among Medicare patients.
Read more